- Home
- CCEL vs GRF Comparison
CCEL vs GRF Comparison
Compare CCEL & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- GRF
- Stock Information
- Founded
- CCEL 1989
- GRF 1989
- Country
- CCEL United States
- GRF United States
- Employees
- CCEL N/A
- GRF N/A
- Industry
- CCEL Managed Health Care
- GRF Finance/Investors Services
- Sector
- CCEL Health Care
- GRF Finance
- Exchange
- CCEL Nasdaq
- GRF Nasdaq
- Market Cap
- CCEL 39.9M
- GRF 39.3M
- IPO Year
- CCEL 1997
- GRF N/A
- Fundamental
- Price
- CCEL $4.90
- GRF $10.07
- Analyst Decision
- CCEL Strong Buy
- GRF
- Analyst Count
- CCEL 1
- GRF 0
- Target Price
- CCEL $8.50
- GRF N/A
- AVG Volume (30 Days)
- CCEL 7.1K
- GRF 3.0K
- Earning Date
- CCEL 07-15-2025
- GRF 01-01-0001
- Dividend Yield
- CCEL 12.50%
- GRF 3.70%
- EPS Growth
- CCEL N/A
- GRF N/A
- EPS
- CCEL N/A
- GRF 1.16
- Revenue
- CCEL $31,988,783.00
- GRF N/A
- Revenue This Year
- CCEL $1.75
- GRF N/A
- Revenue Next Year
- CCEL N/A
- GRF N/A
- P/E Ratio
- CCEL N/A
- GRF $8.15
- Revenue Growth
- CCEL 1.10
- GRF N/A
- 52 Week Low
- CCEL $4.68
- GRF $7.93
- 52 Week High
- CCEL $9.43
- GRF $10.19
- Technical
- Relative Strength Index (RSI)
- CCEL 48.00
- GRF 49.53
- Support Level
- CCEL $4.75
- GRF $9.96
- Resistance Level
- CCEL $5.43
- GRF $10.25
- Average True Range (ATR)
- CCEL 0.26
- GRF 0.15
- MACD
- CCEL 0.01
- GRF -0.03
- Stochastic Oscillator
- CCEL 28.38
- GRF 11.22
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About GRF Eagle Capital Growth Fund Inc.
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.